Pharmacy Sales Representative
About the job
- Candidates should have a commercial profile, management and organizational ability, a proactive and results-oriented attitude, strong analytical ability, facility using programs related to the activity, and Excel skills.
- Manage the commercial plan.
- Optimize results in line with objectives.
- Coordinate with the Marketing Department on customer and visit management.
- Develop turnover considering sell-in and sell-out.
- Increase product referrals for company products.
- Use support materials to increase product visibility at points of sale.
- Learn the product formulary in depth to train pharmacy and assistant teams in pharmacies in the assigned area and answer questions about the laboratory's products and services.
- Know, retain, and develop the pharmacy portfolio in the assigned area.
- Represent the company with an impeccable image.
- Comply with current commercial management standards.
About the company
Laboratoires Expanscience makes natural cosmetic actives and sensory ingredients for skin and body care, with brands like Mustela sold in over 90 countries. The products use 100% natural actives and safe formulations designed to support wellbeing from childhood to seniors, including joint comfort and mental balance. The company differs from rivals by being independently family-owned, French, and B Corp certified, plus a strong focus on social and environmental impact through its impACT program. Its goal is to improve people’s wellbeing while protecting the planet, and to foster a positive, inclusive workplace.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Paris, France
Founded
1950
Get referred to Laboratoires Expanscience
See people who can refer or advise you
Simplify's Take
What believers are saying
- April 2026 OSMOLYA® launch expands premium skin and hair actives into hydration science.
- May 2025 nutraceutical active-ingredient launch opens a new adjacent category beyond cosmetics.
- EUR 5 million by end-2026 boosts API capacity 25%, supporting international demand growth.
What critics are saying
- Stopping Mustela wipes by 2027 removes a familiar revenue line and complicates shelf-space retention.
- Arrow's 2026 takeover of medicine portfolios shrinks Expanscience's pharmaceutical footprint and bargaining power.
- If Epernon's 2026 platform slips, energy costs and emissions targets erode credibility with customers.
What makes Laboratoires Expanscience unique
- 2026 B Corp recertification and mission status reinforce Expanscience's regulated, impact-led brand.
- Epernon's EUR 20 million decarbonization program hardwires manufacturing advantages into French operations.
- 2026 OSMOLYA® and 2025 nutraceutical launches show a differentiated active-ingredients pipeline.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Hybrid Work Options
- Professional Development Budget